Shinya Fujisawa

The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms

W Zhang, Kazunori Ohnishi, Kohichiro Shigeno et al. · Leukemia · 1998 · 160 citations

Cell Division, Medicine, Apoptosis +7

Calicheamicin-conjugated humanized anti-CD33 monoclonal antibody (gemtuzumab zogamicin, CMA-676) shows cytocidal effect on CD33-positive leukemia cell lines, but is inactive on P-glycoprotein-expressing sublines

Kensuke Naito, Akihiro Takeshita, Kohichiro Shigeno et al. · Leukemia · 2000 · 152 citations

Hematological Malignancy, Cytocidal Effect, P-glycoprotein-expressing Sublines +10

Clinicopathological and prognostic characteristics of CD56‐negative multiple myeloma

Akihiro Takeshita, Kazuyuki Shigeno, Shinya Fujisawa et al. · British Journal of Haematology · 2002 · 147 citations

Hematological Malignancy, Cd56‐negative Multiple Myeloma, Autoimmune Disease +13

Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring

Kazunori Ohnishi, Hitoshi Yoshida, Kohichiro Shigeno et al. · Leukemia · 2002 · 99 citations

Careful Electrocardiogram Monitoring, Hematology, Refractory Japanese Patients +2

Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide

Shinya Fujisawa, Ryuzo Ohno, Kazuyuki Shigeno et al. · Cancer Chemotherapy and Pharmacology · 2006 · 64 citations · Full text

Hematological Malignancy, Oncology, Mixed-phenotype Acute Leukemia +8